122 related articles for article (PubMed ID: 11827424)
21. Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part I.
Magilavy D; Polisson R; Murray C
J Bone Joint Surg Am; 2003 Aug; 85(8):1618-9; author reply 1619-20. PubMed ID: 12925653
[No Abstract] [Full Text] [Related]
22. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee.
Adams ME; Lussier AJ; Peyron JG
Drug Saf; 2000 Aug; 23(2):115-30. PubMed ID: 10945374
[TBL] [Abstract][Full Text] [Related]
23. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment.
Goldberg VM; Coutts RD
Clin Orthop Relat Res; 2004 Feb; (419):130-7. PubMed ID: 15021143
[TBL] [Abstract][Full Text] [Related]
24. Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part II.
Waddell DD
J Bone Joint Surg Am; 2003 Aug; 85(8):1620; author reply 1620-1. PubMed ID: 12925654
[No Abstract] [Full Text] [Related]
25. Effectiveness of intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised placebo-controlled trial.
Munteanu SE; Zammit GV; Menz HB; Landorf KB; Handley CJ; Elzarka A; Deluca J
Ann Rheum Dis; 2011 Oct; 70(10):1838-41. PubMed ID: 21791454
[TBL] [Abstract][Full Text] [Related]
26. Acute local reactions after intraarticular hylan for osteoarthritis of the knee.
Puttick MP; Wade JP; Chalmers A; Connell DG; Rangno KK
J Rheumatol; 1995 Jul; 22(7):1311-4. PubMed ID: 7562764
[TBL] [Abstract][Full Text] [Related]
27. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(®)) vs hylan G-F20 (Synvisc(®)) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study.
Pavelka K; Uebelhart D
Osteoarthritis Cartilage; 2011 Nov; 19(11):1294-300. PubMed ID: 21875678
[TBL] [Abstract][Full Text] [Related]
28. Acute local reactions after intraarticular hylan for osteoarthritis of the knee.
Adams ME
J Rheumatol; 1996 May; 23(5):944-5; author reply 946. PubMed ID: 8724316
[No Abstract] [Full Text] [Related]
29. The tolerability of viscosupplementation: low incidence and clinical management of local adverse events.
Waddell DD
Curr Med Res Opin; 2003; 19(7):575-80. PubMed ID: 14626291
[TBL] [Abstract][Full Text] [Related]
30. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
Allard S; O'Regan M
Clin Ther; 2000 Jun; 22(6):792-5. PubMed ID: 10929925
[No Abstract] [Full Text] [Related]
31. [Acute local reaction to intra-articular infiltration with synvisc (Hylan GF20). About two cases].
Noáin E; Sáncez-Villares JJ; Lasanta PJ; González Arteaga FJ
An Sist Sanit Navar; 2003; 26(2):283-5. PubMed ID: 12951623
[TBL] [Abstract][Full Text] [Related]
32. Acute local reactions after intraarticular hylan for osteoarthritis of the knee.
O'Hanlon D
J Rheumatol; 1996 May; 23(5):945-6. PubMed ID: 8724318
[No Abstract] [Full Text] [Related]
33. An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis.
Adams ME
J Rheumatol Suppl; 1993 Aug; 39():16-8. PubMed ID: 8410879
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of intra-articular injections of Hyaluronan and its chemically cross-linked derivative (Hylan G-F20) in normal rabbit knee joints.
Schiavinato A; Finesso M; Cortivo R; Abatangelo G
Clin Exp Rheumatol; 2002; 20(4):445-54. PubMed ID: 12175098
[TBL] [Abstract][Full Text] [Related]
35. Immunological response to bolus versus multiple injections of hylan G-F 20 (Synvisc) in a murine biocompatibility model.
Markel DC; Jackson NM; Esquivel AO; Ren W; Flynn JC
J Biomed Mater Res B Appl Biomater; 2014 Oct; 102(7):1375-80. PubMed ID: 24500880
[TBL] [Abstract][Full Text] [Related]
36. Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis.
Ishikawa M; Yoshioka K; Urano K; Tanaka Y; Hatanaka T; Nii A
Osteoarthritis Cartilage; 2014 Nov; 22(11):1902-9. PubMed ID: 25153804
[TBL] [Abstract][Full Text] [Related]
37. Synovial fluid findings in a patient after hylan GF 20 injection.
Kwan-Morley J; Clayburne G; Schumacher HR
J Clin Rheumatol; 2008 Apr; 14(2):120. PubMed ID: 18391685
[No Abstract] [Full Text] [Related]
38. Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee.
Hammesfahr JF; Knopf AB; Stitik T
Am J Orthop (Belle Mead NJ); 2003 Jun; 32(6):277-83. PubMed ID: 12834190
[TBL] [Abstract][Full Text] [Related]
39. Intra-articular hyaluronans: a review of product-specific safety profiles.
Hamburger MI; Lakhanpal S; Mooar PA; Oster D
Semin Arthritis Rheum; 2003 Apr; 32(5):296-309. PubMed ID: 12701040
[TBL] [Abstract][Full Text] [Related]
40. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
